Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapyWen Xu(Southern Medical University Shenzhen Hospital), Annie LM Cheung(City University of Hong Kong, Shenzhen Research Institute)OncotargetDecember 17, 201410.18632/oncotarget.2781Cited by 70SaveCiteExport RISWatch citationsRelated PapersIdentification of miR-29c and its Target FBXO31 as a Key Regulatory Mechanism in Esophageal Cancer Chemoresistance: Functional Validation and Clinical Significance|Theranostics|2019|58Genome-wide CRISPR/Cas9 screening identifies a targetable MEST-PURA interaction in cancer metastasis|EBioMedicine|2023|25